Hepatocellular carcinoma: Clinical study of long-term survival and choice of treatment modalities

Table 4 Comparison of univariate analysis for various prognostic factors between 5-year survival and 10-year survival groups for hepatocellular carcinoma

Factor	5-yr survival group		10-yr survival group
	Exp (B) 95%CI	P value	Exp (B) 95%CI	P value
Sex (men and women)	0.787 (0.678-0.913)	0.002	0.875 (0.667-1.146)	0.332
Age (yr) (< 50 and ≥ 50)	0.516 (0.462-0.575)	0.000	1.097 (0.838-1.438)	0.500
Diameter of largest tumor	0.971 (0.921-1.023)	0.274	0.961 (0.879-1.051)	0.384
Child-Pugh classification	0.070 (0.060-0.082)	0.000	0.559 (0.334-0.938)	0.028
No. of tumors	1.452 (1.284-1.642)	0.000	0.390 (0.261-0.582)	0.000
Pretreatment serum AFP level	1.041 (0.987-1.099)	0.138	0.933 (0.851-1.022)	0.137
Cirrhosis	0.832 (0.775-0.893)	0.000	10.539 (8.164-13.606)	0.000
TNM stage	0.739 (0.662-0.862)	0.000	0.911 (0.739-1.124)	0.384
Treatment methods	1.152 (1.109-1.197)	0.000	1.043 (0.975-1.115)	0.220
Microvascular invasion	1.038 (0.494-2.181)	0.922	1.233 (0.396-3.838)	0.718

AFP: α-fetoprotein; TNM: Tumor-node-metastasis.